{"id":"metformin-hydrochoride","safety":{"commonSideEffects":[{"rate":"20-30","effect":"Gastrointestinal disturbance (nausea, diarrhea, abdominal discomfort)"},{"rate":"3-5","effect":"Metallic taste"},{"rate":"10-30","effect":"Vitamin B12 deficiency"},{"rate":"<0.1","effect":"Lactic acidosis (rare, in renal impairment)"}]},"_chembl":{"chemblId":"CHEMBL1431","moleculeType":"Small molecule","molecularWeight":"129.17"},"_dailymed":{"setId":"23aa0072-365c-4d13-9aa7-ae23f7e00ee4","title":"METFORMIN HYDROCHLORIDE TABLET, FILM COATED METFORMIN HYDROCHORIDE (METFORMIN) TABLET, FILM COATED [NCS HEALTHCARE OF KY, LLC DBA VANGARD LABS]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Metformin is a biguanide that activates AMP-activated protein kinase (AMPK) and inhibits mitochondrial glycerol-3-phosphate dehydrogenase, leading to decreased gluconeogenesis in the liver. It also enhances peripheral glucose uptake and utilization by muscle and adipose tissue, improving overall insulin sensitivity without stimulating insulin secretion.","oneSentence":"Metformin reduces hepatic glucose production and improves insulin sensitivity, thereby lowering blood glucose levels in type 2 diabetes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:00:41.314Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes mellitus"},{"name":"Prediabetes (off-label/prevention)"}]},"trialDetails":[{"nctId":"NCT04930744","phase":"PHASE2","title":"Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)","status":"COMPLETED","sponsor":"University of Massachusetts, Worcester","startDate":"2021-08-26","conditions":"Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection","enrollment":112},{"nctId":"NCT03236740","phase":"PHASE4","title":"OCP vs Metformin on Ovarian Stromal Blood Flow in PCOS","status":"COMPLETED","sponsor":"S.C.B. Medical College and Hospital","startDate":"2017-08-01","conditions":"PCOS","enrollment":101}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ABDOMINAL PAIN UPPER"},{"count":1,"reaction":"APOLIPOPROTEIN A-I DECREASED"},{"count":1,"reaction":"BLOOD PRESSURE INCREASED"},{"count":1,"reaction":"DIABETES MELLITUS INADEQUATE CONTROL"},{"count":1,"reaction":"GASTROINTESTINAL HAEMORRHAGE"},{"count":1,"reaction":"GLYCOSYLATED HAEMOGLOBIN INCREASED"},{"count":1,"reaction":"HIGH DENSITY LIPOPROTEIN DECREASED"},{"count":1,"reaction":"INTESTINAL OBSTRUCTION"},{"count":1,"reaction":"MYOCARDIAL ISCHAEMIA"}],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Glucophage"],"phase":"marketed","status":"active","brandName":"Metformin hydrochoride","genericName":"Metformin hydrochoride","companyName":"University of Massachusetts, Worcester","companyId":"university-of-massachusetts-worcester","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Metformin reduces hepatic glucose production and improves insulin sensitivity, lowering blood glucose levels in type 2 diabetes. Used for Type 2 diabetes mellitus, Prediabetes (prevention of progression to type 2 diabetes), Polycystic ovary syndrome (PCOS).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}